(MedPage Today) — Sun Pharmaceutical issued a voluntary recall of lisdexamfetamine dimesylate capsules, used for attention deficit-hyperactivity disorder (ADHD), after failing dissolution tests, the FDA said.
A randomized trial showed that message…
Source link : https://www.medpagetoday.com/psychiatry/generalpsychiatry/118324
Author :
Publish date : 2025-11-05 19:35:00
Copyright for syndicated content belongs to the linked Source.
